SEMGLEE (Insulin Glargine) 100U/mL

Introduction to Lantus (Insulin Glargine) 100U/mL 

Lantus (Insulin Glargine) 100U/mL is a long-acting prescription insulin used to improve blood sugar control in people with diabetes mellitus. It is commonly prescribed for both type 1 diabetes and type 2 diabetes as part of a long-term glucose management plan. Insulin glargine provides a steady release of insulin over 24 hours, helping maintain stable blood glucose levels throughout the day and night.

Lantus (Insulin Glargine) 100U/mL is classified under Prescription Medicines, Antidiabetic Medicines, Long-Acting Insulin Analogues, and Injectable Diabetes Therapies. It contains Insulin Glargine, a biosimilar basal insulin that works by replacing or supplementing the body’s natural insulin.

In some markets, SEMGLEE 100U/mL is available as a biosimilar brand containing the same active ingredient Insulin Glargine, offering a similar therapeutic effect when prescribed by a qualified healthcare professional. SEMGLEE has been approved as a biosimilar to Lantus and is available in vial and prefilled pen presentations in several markets.

What Is Lantus (Insulin Glargine)? 

Lantus is the original brand name for Insulin Glargine, a long-acting basal insulin used to help regulate blood glucose in patients with diabetes mellitus. It is designed to provide a consistent insulin level for up to 24 hours with once-daily dosing in many patients.

Insulin Glargine belongs to a class of medicines known as Long-Acting Insulin Analogues. These medicines are used to provide background insulin coverage and help prevent blood sugar fluctuations between meals and overnight.

Biosimilar versions such as SEMGLEE 100U/mL contain the same active insulin analogue and may be used depending on physician recommendation and regional availability.

Drug Class and Mechanism of Action 

Insulin Glargine is classified as a long-acting recombinant human insulin analogue with glucose-lowering properties.

How Insulin Glargine Works 

It works in several ways:

• Helps glucose move from the bloodstream into body cells
• Reduces excess sugar production by the liver
• Supports steady background insulin coverage over an extended period
• Helps maintain fasting and between-meal blood sugar control

Through these mechanisms, Insulin Glargine helps reduce hyperglycemia and supports long-term diabetes management.

How Lantus Works in the Body 

In diabetes, the body either does not produce enough insulin or cannot use insulin properly. Lantus helps replace missing basal insulin and supports stable blood glucose control over the day and night.

Key Actions of Insulin Glargine 

• Provides prolonged insulin activity after subcutaneous injection
• Helps lower fasting blood sugar levels
• Reduces glucose output from the liver
• Supports consistent day-to-day glycemic control

Some biosimilar versions such as SEMGLEE deliver the same active compound, allowing similar long-acting insulin therapy when prescribed appropriately.

Medical Uses of Lantus (Insulin Glargine) 100U/mL 

Lantus 100U/mL is widely prescribed for the long-term control of blood glucose in diabetes mellitus.

Lantus for Type 1 Diabetes 

For patients with type 1 diabetes, Lantus is commonly used as a basal insulin together with short-acting or rapid-acting mealtime insulin.

Potential Benefits 

• Improved fasting blood sugar control
• Better 24-hour insulin coverage
• Reduced day-to-day glucose variability
• Support for individualized insulin regimens

Biosimilar alternatives like SEMGLEE 100U/mL may also be used under medical supervision when Insulin Glargine therapy is recommended.

Lantus for Type 2 Diabetes 

Lantus is also prescribed for adults with type 2 diabetes when oral medicines, lifestyle changes, or other therapies do not provide adequate blood sugar control. In some patients, it may be used with other antidiabetic medicines.

Treatment Benefits 

• Better fasting glucose control
• Support for HbA1c improvement
• Convenient once-daily dosing for many patients
• May be combined with oral diabetes medicines under medical supervision

Who Can Take SEMGLEE 100U/mL? 

Because Insulin Glargine is a prescription insulin, treatment should always be supervised by a qualified healthcare professional.

Eligibility Criteria 

Patients may be prescribed Lantus or SEMGLEE if they:

• Have type 1 diabetes
• Have type 2 diabetes requiring basal insulin support
• Need long-acting insulin for blood sugar control
• Can properly follow injection technique and glucose monitoring instructions

Certain biosimilar options such as SEMGLEE may also be considered depending on availability and physician decision. SEMGLEE is indicated in adults and children with diabetes in some markets, though age cutoffs may vary by region.

Who Should Avoid Lantus (Insulin Glargine) 100U/mL 

Lantus or SEMGLEE should NOT be used by:

• Patients having an active episode of hypoglycemia (low blood sugar)
• Individuals with known hypersensitivity to Insulin Glargine or any of the product ingredients
• Patients needing emergency treatment for diabetic ketoacidosis (DKA), as this medicine is not recommended for that purpose

Lantus (Insulin Glargine) 100U/mL Dosage and Administration 

Standard Dosage Guidelines 

Typical dosage recommendations include:

• SEMGLEE 100U/mL or Lantus is usually injected once daily
• It should be taken at the same time each day
• Given by subcutaneous injection
• Common injection sites include the abdomen, thigh, or upper arm
• Dose is individualized based on blood glucose levels, insulin needs, and physician guidance

Dosage Adjustments 

Doctors may adjust the dose depending on:

• Blood sugar monitoring results
• Changes in diet or physical activity
• Kidney or liver function
• Use of other diabetes medicines
• Risk of hypoglycemia or hyperglycemia

Side Effects of Lantus (Insulin Glargine) 100U/mL

Like all insulin medicines, Lantus or SEMGLEE may cause side effects.

Common Side Effects 

• Hypoglycemia (low blood sugar)
• Injection site reactions
• Weight gain
• Swelling in hands or feet
• Mild skin irritation or redness at the injection site

Serious Side Effects 

• Severe Hypoglycemia: May lead to confusion, fainting, or seizures
• Allergic Reactions: Rash, breathing difficulty, or swelling
• Low Potassium (Hypokalemia): Can become serious if untreated
• Medication Errors: Accidental mix-ups with other insulin products can occur
• Heart Failure Risk: When used with certain diabetes medicines such as TZDs in susceptible patients

Patients should report any unusual symptoms to their doctor immediately.

Storage:
Store under refrigerated conditions before first use as directed on the product label. Do not freeze. After first use, storage conditions may vary by product presentation and local labeling, so patients should always follow the manufacturer’s instructions and pharmacist guidance. Keep out of direct sunlight and out of reach of children.

Frequently Asked Questions (FAQs) 

1. Is Lantus (Insulin Glargine) 100U/mL a long-acting insulin? 

Yes. Lantus and SEMGLEE are long-acting basal insulin analogues used to provide steady blood sugar control over an extended period.

2. Is SEMGLEE the same as Lantus? 

SEMGLEE contains Insulin Glargine, the same active insulin analogue used in Lantus. It is considered a biosimilar or interchangeable option in certain markets depending on local regulatory approval.

3. Can Lantus or SEMGLEE be used for type 2 diabetes? 

Yes. It is commonly prescribed for type 2 diabetes when better blood sugar control is needed, especially for fasting glucose management.

4. Can I use SEMGLEE to treat diabetic ketoacidosis (DKA)? 

No. SEMGLEE is not recommended for the treatment of diabetic ketoacidosis. DKA requires urgent medical treatment using appropriate short-acting insulin and supportive care.

5. Can I share my insulin pen with someone else? 

No. Patients should never share insulin pens, even if the needle has been changed, because this may spread serious infections.

6. Do I need a prescription to buy SEMGLEE (Insulin Glargine) 100U/mL? 

Yes. SEMGLEE 100U/mL is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.

7. What forms is SEMGLEE available in? 

SEMGLEE has been marketed in vial and prefilled pen presentations in multiple regions. Availability may differ depending on country and supplier.

Medical Disclaimer 

Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Lantus (Insulin Glargine) 100U/mL and SEMGLEE are prescription-only insulin medicines and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.